Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Figure 6

Kaplan-Meyer plot of cumulative proportion of patients remaining free from any disease activity over time from start of fingolimod therapy.